One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-111935
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 5 |
Affiliation: Memorial Sloan Kettering Cancer Center, Atrium Health Wake Forest Baptist, New York Blood Center, Icahn School of Medicine at Mount Sinai, The University of Texas Health Science Center, The University of Texas Health Science Center at San Antonio, Cleveland Clinic, University of Chicago, Mayo Clinic, Tisch Hospital, Roswell Park Cancer Institute, University of Pennsylvania, Washington University in St. Louis, Columbia University Irving Medical CenterEfficacy of Combined Ruxolitinib and Decitabine in Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms: Results of a Phase II Study (MPN-RC 109 trial)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
